154 related articles for article (PubMed ID: 29994904)
1. Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies.
Bajpai R; Shanmugam M
Curr Opin Oncol; 2018 Sep; 30(5):338-344. PubMed ID: 29994904
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
4. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
[TBL] [Abstract][Full Text] [Related]
5. ASCT2: a potential cancer drug target.
Wahi K; Holst J
Expert Opin Ther Targets; 2019 Jul; 23(7):555-558. PubMed ID: 31159623
[No Abstract] [Full Text] [Related]
6. Targeting cellular metabolism to improve cancer therapeutics.
Zhao Y; Butler EB; Tan M
Cell Death Dis; 2013 Mar; 4(3):e532. PubMed ID: 23470539
[TBL] [Abstract][Full Text] [Related]
7. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X
J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies impacting cancer cell glutamine metabolism.
Lukey MJ; Wilson KF; Cerione RA
Future Med Chem; 2013 Sep; 5(14):1685-700. PubMed ID: 24047273
[TBL] [Abstract][Full Text] [Related]
9. Targeting lactate metabolism for cancer therapeutics.
Doherty JR; Cleveland JL
J Clin Invest; 2013 Sep; 123(9):3685-92. PubMed ID: 23999443
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
Marchiq I; Pouysségur J
J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
[TBL] [Abstract][Full Text] [Related]
11. Glucose transporters in cancer metabolism.
Adekola K; Rosen ST; Shanmugam M
Curr Opin Oncol; 2012 Nov; 24(6):650-4. PubMed ID: 22913968
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic targets of tumor metabolism.
Kishton RJ; Rathmell JC
Cancer J; 2015; 21(2):62-9. PubMed ID: 25815845
[TBL] [Abstract][Full Text] [Related]
13. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
Ganapathy V; Thangaraju M; Prasad PD
Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.
Yang WH; Qiu Y; Stamatatos O; Janowitz T; Lukey MJ
Trends Cancer; 2021 Aug; 7(8):790-804. PubMed ID: 34020912
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.
Matés JM; Di Paola FJ; Campos-Sandoval JA; Mazurek S; Márquez J
Semin Cell Dev Biol; 2020 Feb; 98():34-43. PubMed ID: 31100352
[TBL] [Abstract][Full Text] [Related]
16. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer.
Kim S; Kim DH; Jung WH; Koo JS
Endocr Relat Cancer; 2013 Jun; 20(3):339-48. PubMed ID: 23507704
[TBL] [Abstract][Full Text] [Related]
17. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.
Bolzoni M; Chiu M; Accardi F; Vescovini R; Airoldi I; Storti P; Todoerti K; Agnelli L; Missale G; Andreoli R; Bianchi MG; Allegri M; Barilli A; Nicolini F; Cavalli A; Costa F; Marchica V; Toscani D; Mancini C; Martella E; Dall'Asta V; Donofrio G; Aversa F; Bussolati O; Giuliani N
Blood; 2016 Aug; 128(5):667-79. PubMed ID: 27268090
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells.
Polet F; Martherus R; Corbet C; Pinto A; Feron O
Oncotarget; 2016 Jul; 7(29):46371-46383. PubMed ID: 27344174
[TBL] [Abstract][Full Text] [Related]
19. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
[TBL] [Abstract][Full Text] [Related]
20. SLC38A2 Overexpression Induces a Cancer-like Metabolic Profile and Cooperates with SLC1A5 in Pan-cancer Prognosis.
Huang MS; Chang JH; Lin WC; Cheng YH; Li FA; Suen CS; Hwang MJ; Chang CK; Mou KY
Chem Asian J; 2020 Nov; 15(22):3861-3872. PubMed ID: 32996252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]